Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
20 5월 2024 - 8:00PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of May 2024
Commission File Number: 001-39088
Aesthetic Medical International Holdings Group
Limited
1122
Nanshan Boulevard
Nanshan District, Shenzhen
Guangdong Province, China 518052
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: May 20, 2024 |
Aesthetic Medical International Holdings Group Limited |
|
|
|
By: |
/s/ Guanhua Wu |
|
Name: |
Guanhua Wu |
|
Title: |
Chief Financial Officer |
Exhibit 99.1
Aesthetic Medical International Holdings Group
Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel
Shenzhen,
China, May 20, 2024 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company”
or “AIH”), a leading provider of aesthetic medical services in China, today announced that it has received a determination
letter of the Hearings Panel (the “Panel”) of The Nasdaq Capital Market (“Nasdaq”) dated May 17, 2024, notifying
the Company that the Panel determined to delist the Company’s securities from Nasdaq, due to the failure to satisfy the continued
listing conditions as previously disclosed. As a result, the Company expects that its securities will be suspended from trading at the
open of business on May 21, 2024 and delisted from Nasdaq after the completion of Nasdaq’s filing of a Form 25 Notification
of Delisting with the Securities and Exchange Commission after all appeal periods have expired. The Company does not intend to file an
appeal of the determination.
Following the delisting, the Company expects that
its American Depositary Shares (the “ADSs”) will be quoted on the “over the counter” market operated by OTC Markets
Group Inc (the “OTC”) so that a trading market may continue to exist for its ADSs. There is no guarantee, however, that a
broker will continue to make a market in the ADSs and that trading of the ADSs will continue on an OTC market or otherwise.
The delisting from Nasdaq will have no significant
impact on the Company’s operations in the aesthetic medical industry in mainland China. The Company is committed to enhancing operational
management and efficiency and aims to drive performance growth.
About Aesthetic Medical International Holdings Group Limited
AIH, known as “Peng’ai” in China,
is a leading provider of aesthetic medical services in China. AIH operates through treatment centers that are spread across major cities
in mainland China, with a major focus on the Guangdong-Hong Kong-Macau Greater Bay area and the Yangtze River Delta area. Leveraging over
20 years of clinical experience, AIH provides one-stop aesthetic service offerings, including surgical aesthetic treatments, non-surgical
aesthetic treatments, general medical services, and other aesthetic services. For more information regarding the Company, please visit
https://ir.aihgroup.net/.
Cautionary Statements
This press release contains “forward-looking
statements.” These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will”, “expects”,
“anticipates”, “aims”, “future”, “intends”, “plans”, “believes”,
“estimates”, “likely to” and similar statements. Statements that are not historical facts, including statements
about the Company’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent
risks and uncertainties. These risks and uncertainties and others that relate to the Company’s business and financial condition
are detailed from time to time in the Company’s SEC filings, and could cause the actual results to differ materially from those
contained in any forward-looking statement. These forward-looking statements are made only as of the date indicated, and the Company undertakes
no obligation to update or revise the information contained in any forward-looking statements, except as required under applicable law.
Investor Relations Contacts
For investor and media inquiries, please contact:
Aesthetic Medical International Holdings Group Limited
Email: ir@pengai.com.cn
Website: https://ir.aihgroup.net
Aesthetic Medical (NASDAQ:AIH)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Aesthetic Medical (NASDAQ:AIH)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024